0 Comentários
0 Compartilhamentos
437 Visualizações
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça o login para curtir, compartilhar e comentar!
- Luliconazole Cream Market to Reach USD 683 Million by 2034 | CAGR 5.8%According to a newly published market research report by 24LifeSciences, global luliconazole cream market was valued at USD 427 million in 2025 and is projected to reach USD 683 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 20262034. Luliconazole cream is a broad-spectrum antifungal medication belonging to the imidazole class, clinically...0 Comentários 0 Compartilhamentos 705 Visualizações
- Market Opportunities in Panthenol for Pharmaceutical IndustryThe global panthenol market was valued at USD 36.7 million in 2025 and is anticipated to reach USD 59.4 million by 2033, registering a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2026 to 2033. This growth trajectory is largely attributed to the continuous expansion of the cosmetics and personal care sector, where panthenol is widely recognized for its...0 Comentários 0 Compartilhamentos 224 Visualizações
- Pharmaceutical Industry Embraces Hybrid Models, Boosting Decentralized Clinical Trials Market GrowthThe Decentralized Clinical Trials Market has evolved from an innovative concept into a structural shift in how clinical research operates. Traditional site-based trials, where participants travel regularly to centralized hospitals or research centers, no longer represent the only viable model. Advances in digital health technologies, regulatory flexibility, and patient-centric design...0 Comentários 0 Compartilhamentos 1189 Visualizações
- RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...0 Comentários 0 Compartilhamentos 585 Visualizações
© 2026 Mạng xã hội kotra-hanoi.org.vn
Portuguese (Brazil)